Differences in expression of apoptosis regulatory proteins in idiopathic pulmonary fibrosis and cryptogenic organizing pneumonia

M. Plataki, A. V. Koutsopoulos, H. Tzortzaki, C. Dambaki, N. Tzanakis, E. Stathopoulos, D. Bouros, N. M. Siafakas (Heraklion, Alexandroupolis, Greece)

Source: Annual Congress 2006 - Clinical features of interstitial lung disease
Session: Clinical features of interstitial lung disease
Session type: Electronic Poster Discussion
Number: 1765
Disease area: Interstitial lung diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Plataki, A. V. Koutsopoulos, H. Tzortzaki, C. Dambaki, N. Tzanakis, E. Stathopoulos, D. Bouros, N. M. Siafakas (Heraklion, Alexandroupolis, Greece). Differences in expression of apoptosis regulatory proteins in idiopathic pulmonary fibrosis and cryptogenic organizing pneumonia. Eur Respir J 2006; 28: Suppl. 50, 1765

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Cykine/receptor inflammatory profile in different types of idiopathic intestitial pneumonias (IIPs). Key role of Fas Ligand recruvation in idiopathic pulmonary fibrosis (IPF)
Source: Annual Congress 2010 - Biomarkers in diffuse parenchymal lung disease
Year: 2010


Expression of apoptotic markers in patients with idiopathic pulmonary fibrosis
Source: Eur Respir J 2003; 22: Suppl. 45, 376s
Year: 2003

Distinctive polarization of circulating classical monocytes between idiopathic pulmonary fibrosis and idiopathic nonspecific interstitial pneumonia.
Source: Virtual Congress 2020 – Biomarkers and mechanistic aspects of idiopathic pulmonary fibrosis
Year: 2020


Differences of acute exacerbations in idiopathic pulmonary fibrosis compared to other fibrotic lung diseases
Source: International Congress 2019 – The world of idiopathic pulmonary fibrosis
Year: 2019

Possible target genes in idiopathic pulmonary fibrosis
Source: Annual Congress 2007 - PG9 - Molecular pathology and genetics in lung diseases
Year: 2007

Lymphatic fluctuation in parenchymal remodelling stage of organising pneumonia, nonspecific interstitial pneumonia and idiopathic pulmonary fibrosis
Source: Annual Congress 2009 - Various backgrounds in diffuse parenchymal lung disease
Year: 2009


VEGF expression does not differentiate between idiopathic pulmonary fibrosis and pulmonary sarcoidosis
Source: Eur Respir J 2007; 30: Suppl. 51, 574s
Year: 2007

Histology and pathogenesis of usual interstitial pneumonia (UIP) versus nonspecific interstitial pneumonia (NSIP): progressive remodeling or resolution and healing?
Source: Annual Congress 2006 - Usual interstitial pneumonia (UIP) and nonspecific interstitial pneumonia (NSIP), idiopathic or not: new concepts in diagnosis and treatment
Year: 2006


Idiopathic pulmonary fibrosis: multiple causes and multiple mechanisms?
Source: Eur Respir J 2007; 30: 835-839
Year: 2007



Inhibition of local fibrinolysis differs between idiopathic pulmonary fibrosis (IPF) and fibrotic non-specific interstitial pneumonia (f-NSIP)
Source: Annual Congress 2009 - Idiopathic pulmonary fibrosis: concepts and mechanisms
Year: 2009

The classification, natural history and radiological/histological appearance of idiopathic pulmonary fibrosis and the other idiopathic interstitial pneumonias
Source: Eur Respir Rev 2008; 17: 108-115
Year: 2008



NHLRC2 mRNA and protein expression in idiopathic pulmonary fibrosis
Source: Virtual Congress 2021 – Translational and other aspects of idiopathic interstitial pneumonia
Year: 2021


Bronchiolitis as a component in idiopathic pulmonary fibrosis and idiopathic interstitial pneumonias: clinico-pathological characteristics
Source: Eur Respir J 2004; 24: Suppl. 48, 534s
Year: 2004

Analysis of small airway function in patients with idiopathic interstitial pneumonia
Source: Annual Congress 2008 - Clinical aspects of interstitial lung disease
Year: 2008

Difference between pathogenic and inhibitory bacterial florae is associated with acute exacerbation of idiopathic pulmonary fibrosis
Source: Virtual Congress 2020 – Prognosis and biomarkers of idiopathic pulmonary fibrosis
Year: 2020


Asymmetry in acute exacerbation of idiopathic pulmonary fibrosis
Source: ERJ Open Res, 3 (2) 00036-2016; 10.1183/23120541.00036-2016
Year: 2017



Idiopathic pulmonary fibrosis (IPF) and idiopathic nonspecific interstitial pneumonia (NSIP): what treatment and for whom?
Source: Annual Congress 2006 - Usual interstitial pneumonia (UIP) and nonspecific interstitial pneumonia (NSIP), idiopathic or not: new concepts in diagnosis and treatment
Year: 2006


Clinical significance of histological classification of idiopathic interstitial pneumonia
Source: Eur Respir J 2002; 19: 275-283
Year: 2002



Plasma protein signature of idiopathic pulmonary fibrosis (IPF)
Source: Annual Congress 2013 –Translational research to bridge the need within clinical decision making
Year: 2013

Evaluation of functional capacity and pulmonary functions during acute pulmonary exacerbation in children with cystic fibrosis
Source: Virtual Congress 2020 – Exercise tolerance and functional status across respiratory diseases
Year: 2020